Abstract
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced that the new IVD configuration of its Accelerate PhenoTest BC kit has been CE marked and is ready for use in Europe. The new configuration, which launched in the United States in July, provides fast antimicrobial susceptibility testing (AST) results in approximately 7 hours direct from positive blood cultures and is designed to run on the Accelerate Pheno system as a flexible solution for laboratories that already have a rapid identification system.
Key Data
-
Publication Date03 August 2021
-
Primary AuthorAccelerate Diagnostics, Inc.
-
SourcePR Newswire
-
LanguageEnglish
Click below to visit original source: